Using cluster analysis to identify dermatologist and internist prescribing phenotypes for acne management - 17/02/22
Doi : 10.1016/j.jaad.2021.02.068
John S. Barbieri, MD, MBA a, ⁎ 
, David J. Margolis, MD, PhD a, b
, David J. Margolis, MD, PhD a, b a Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania
b Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania
∗Correspondence to: John S. Barbieri, MD, MBA, Perelman Center for Advanced Medicine, 3400 Civic Center Boulevard, 7th Floor, South TowerPerelman Center for Advanced Medicine3400 Civic Center Boulevard7th FloorSouth Tower
| Funding sources: Dr Barbieri receives partial salary support through a Pfizer Fellowship in Dermatology Patient Oriented Research grant to the Trustees of the University of Pennsylvania. The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. |
|
| IRB approval status: This study was deemed exempt the University of Pennsylvania Institutional Review Board. |
|
| Reprints not available from the authors. |
© 2021
American Academy of Dermatology, Inc.. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 86 - N° 3
P. 679-681 - marzo 2022 Ritorno al numero
Articolo precedente
- Dapsone as corticosteroid-sparing therapy for Sweet syndrome
- Matthew L. Hrin, Steven R. Feldman, William W. Huang
- Identifying sociodemographic factors associated with hospitalization following primary excision of cutaneous melanoma
- Christopher R. Cullison, Raghav Tripathi, Jeremy S. Bordeaux
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?